By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors) > Cemiplimab
Anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)

Cemiplimab

https://themeditary.com/drug/cemiplimab-7323.html
Medically Reviewed by Glamora Samuels, MD TheMediTary.Com | Reviewed: Aug 15, 2023  Additional Content by TheMediTary.Com

Generic name: cemiplimab [ se-mip-li-mab ]

Drug class: Anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)

Dosage form: intravenous solution (rwlc 350 mg/7 ml)

Availability: Prescription only

Pregnancy & Lactation: Risk data available

Brand names: Libtayo

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

What is Cemiplimab?

Cemiplimab is used to treat certain cancers of the skin.

Cemiplimab is also used alone or in combination with other cancer drugs to treat lung cancer that has not spread outside your chest.

Cemiplimab is often used when the cancer has spread to other parts of the body (metastatic), or cannot be treated with other cancer drugs, radiation, or surgery.

Your doctor may perform a biopsy to test your cancer for a protein called "PD-L1," or a specific genetic marker (an abnormal "EGFR," "ALK," or "ROS1" gene).

Cemiplimab may also be used for purposes not listed in this medication guide.

Warnings

Cemiplimab strengthens your immune system to help your body fight against cancer cells. This may cause the immune system to attack normal healthy tissues or organs. When this happens, you may develop serious or life-threatening medical problems.

Call your doctor at once if you have new or worsening symptoms such as: chest pain, cough, breathing problems, swelling, nausea, vomiting, changes in appetite or weight, stomach pain, easy bruising or bleeding, mood or behavior changes, severe weakness, vision problems, hair loss, increased or decreased urination, blood in your urine, dark urine, or yellowing of the skin or eyes.

How should I take Cemiplimab

Cemiplimab is given as an infusion into a vein. A healthcare provider will give you this injection.

This medicine must be given slowly, and the infusion can take at least 30 minutes to complete.

Cemiplimab is usually given once every 3 weeks until your body no longer responds to the medication.

You will need frequent medical tests.

Dosing information

Usual Adult Dose for Squamous Cell Carcinoma:

350 mg IV over 30 minutes every 3 weeks until disease progression or unacceptable toxicity

Use: For the treatment of patients with metastatic cutaneous squamous cell carcinoma (CSCC) or locally advanced CSCC who are not candidates for curative surgery or curative radiation

Usual Adult Dose for Basal Cell Carcinoma:

350 mg IV over 30 minutes every 3 weeks until disease progression or unacceptable toxicity

Uses:
-For locally advanced basal cell carcinoma (laBCC) previously treated with a hedgehog pathway inhibitor or for whom a hedgehog pathway inhibitor is not appropriate
-For metastatic BCC (mBCC) previously treated with a hedgehog pathway inhibitor or for whom a hedgehog pathway inhibitor is not appropriate

Detailed Cemiplimab dosage information
Cemiplimab Dosage information (more detail)

Before Taking

Tell your doctor if you have ever had:

  • an immune system disorder such as lupus, ulcerative colitis, or Crohn's disease;

  • a nervous system problem, such as myasthenia gravis or Guillain-Barré syndrome;

  • radiation treatment to your chest area; or

  • an organ transplant.

Tell your doctor if you have received or plan to receive a stem cell transplant using donor stem cells.

You may need to have a negative pregnancy test before starting this treatment.

Cemiplimab may harm an unborn baby. Use effective birth control to prevent pregnancy while you are using cemiplimab and for at least 4 months after your last dose. Tell your doctor if you become pregnant.

Do not breastfeed while using this medicine, and for at least 4 months after your last dose.

What happens if I miss a dose?

Call your doctor for instructions if you miss an appointment for your cemiplimab injection.

What happens if I overdose?

Since cemiplimab is given by a healthcare professional in a medical setting, an overdose is unlikely to occur.

What should I avoid while using Cemiplimab?

Follow your doctor's instructions about any restrictions on food, beverages, or activity.

Cemiplimab side effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Seek medical treatment if you have a serious drug reaction that can affect many parts of your body. Symptoms may include fever, swollen glands, muscle aches, severe weakness, unusual bruising, or yellowing of your skin or eyes, sore throat, burning eyes, skin pain, red or purple skin rash with blistering and peeling.

Some side effects may occur during the injection. Tell your caregiver right away if you feel dizzy, shaky, light-headed, nauseated, chilled or feverish, itchy, tingly, or have a rash, neck or back pain, trouble breathing, or swelling in your face.

Cemiplimab strengthens your immune system to help your body fight against cancer cells. This may cause the immune system to attack normal healthy tissues or organs. When this happens, you may develop serious or life-threatening medical problems.

Cemiplimab may cause serious side effects. Call your doctor at once if you have:

  • new or worsening cough, shortness of breath;

  • painful sores in your nose or genital area;

  • chest pain, fast or irregular heartbeats;

  • swollen glands;

  • severe headache, confusion, memory problems, hallucinations;

  • eye pain or redness, vision problems (your eyes may be more sensitive to light);

  • severe muscle pain or weakness, neck stiffness, problems with balance;

  • severe stomach pain, nausea, vomiting, diarrhea, bloody or tarry stools;

  • unusual bruising;

  • transplant rejection--mouth sores, stomach pain, feeling sick or uneasy, rash, pain or swelling near your transplanted organ;

  • kidney problems--swelling in your ankles, blood in your urine, little or no urination;

  • liver problems--right-sided upper stomach pain, loss of appetite, drowsiness, easy bruising or bleeding, dark urine, jaundice (yellowing of the skin or eyes); or

  • signs of a hormonal disorder--frequent or unusual headaches, dizziness, feeling very tired, mood or behavior changes, hoarse or deepened voice, increased hunger or thirst, increased urination, constipation, hair loss, sweating, feeling cold, weight gain, or weight loss.

Your cancer treatments may be delayed or permanently discontinued if you have certain side effects.

Common side effects of cemiplimab may include:

  • tiredness;

  • hair loss;

  • numbness, pain, tingling or burning in your hands or feet;

  • muscle or bone pain;

  • rash; or

  • nausea, diarrhea, loss of appetite.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

See more: Cemiplimab Side Effects

What other drugs will affect Cemiplimab?

Other drugs may affect cemiplimab, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.

More about Cemiplimab (Cemiplimab [ se-mip-li-mab ])

Dosage information
Cemiplimab Side Effects
During pregnancy
Drug images
Side effects
Breastfeeding Warnings
Drug class: Anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)

Related treatment guides

Squamous Cell Carcinoma
Non-Small Cell Lung Cancer
Basal Cell Carcinoma
Share this Article
Contents
Uses Warnings Before Taking Dosage Side effects Interactions
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by